The major pharmas are loaded up with trillions in firepower—but are sticking to mid-cap deals. One expert says it might be ...

Nasus Pharma Ltd. NSRX shares are down on Wednesday following the company's continuous weakness after the announcement of ...

POTOMAC, MD / ACCESS Newswire / March 18, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a ...

Strides Pharma Science is preparing to enhance its presence in Sub-Saharan Africa by acquiring branded generic products from ...

Gesynta Pharma has dosed the first patient in its Phase II trial, NOVA, investigating vipoglanstat, a non-hormonal, ...

During this latest round of earnings calls, marketing didn’t factor heavily in these discussions. Lilly did address sharply ...

While Johnson & Johnson retains the top revenue rank across the major pharma companies, Eli Lilly last year established ...

The pharmaceutical industry is engaging in a flurry of biotech deals and shifting clinical trials to China. It does so at a ...

Rapid Micro Biosystems, Inc. sees strong FY25 revenue growth from Growth Direct placements, but losses persist. Click for ...

In this week’s episode of “The Top Line,” we take a deep dive into the fourth-quarter performance of the biopharma industry ...

NervGen Pharma Corp. NVG-291 shows lasting gains in chronic spinal cord injury; Phase 3 and FDA fast paths ahead. Click for this NGEN update.

UVeCARE earned major recognition at the Natural Health Readers' Choice Awards 2025, winning the prestigious Natural ...